Mucosal tenofovir 1% gel stimulates cell proliferation and type I/III interferon pathways.
(2026 Mar 23)
Microbiol Spectr 14(5): e0168025
Hughes SM, Calienes FL, Levy CN, Pandey U, Gornalusse GG, Cranston RD, Lama JR, Pickett J, Brand RM, Hendrix CW, Marzinke MA, Dai JY, Balar B, Justman JE, Nair G, Berard AR, Birse K, Noel-Romas L, Mayer KH, Stekler JD, Mackelprang R, Burgener AD, McGowan I, Cameron CM, Cameron MJ, Woodrow KA, Hladik F

The Critical Importance of Clinical Use Case to Inform Point-of-Care Technology Development: A Case Study of HIV Nucleic Acid Assays in the United States.
(2026 Feb 9)
Clin Infect Dis 82(1): e93-e99
Manabe YC, Hamill MM, Palamountain KM, Achenbach CJ, Delaney KP, Hsieh YH, Jones JL, Kirby RP, McFall SM, Osburn WO, Ray SC, Rothman RE, Stekler JD, Katz DA

Randomized Controlled Trial of a HIV Prevention App to Increase Pre-exposure Prophylaxis Uptake Among Gay and Bisexual Men Who Have Sex With Men in the United States: The HealthMindr PrEP Study.
(2025 Dec 15)
J Acquir Immune Defic Syndr 100(5): 425-434
Jones J, Schneider I, Valencia R, Jenness SM, Butler G, Castel AD, Kulie P, Stephenson R, Stekler JD, Mena L, Sullivan PS

Preferences for HIV Pre-Exposure Prophylaxis Products and Delivery Models Among Cisgender Men, Transgender Persons, and Nonbinary Individuals Who Have Sex With Men in Seattle, Washington: A Discrete Choice Experiment.
(2025 Oct 1)
J Acquir Immune Defic Syndr 100(2): 105-114
Violette LR, Delacruz J, Niemann LA, Cannon C, Stekler JD, Katz DA

Development of a Highly Multiplexed RT-LAMP Assay for Coverage of Genetic Sequence Diversity.
(2025 Feb 25)
Anal Chem 97(7): 4005-4013
Gilligan-Steinberg SD, Kline EC, Wang Q, Britton RJ, Kim W, Rupp JW, Gu H, Beck IA, Hull IT, Panpradist N, Stekler JD, Frenkel LM, Drain PK, Lai JJ, Lutz BR